Maternal nutrient restriction alters gene expression in the ovine fetal heart

Journal of Physiology

Volumn 558, Issue 1, 2004, Pages 111-121

  Han, Hyung Chul ^a   Austin, Kathleen J ^a   Nathanielsz, Peter W ^b   Ford, Stephen P ^a   Nijland, Mark J ^b   Hansen, Thomas R ^a  

^a UNIVERSITY OF WYOMING   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANKYRIN; CAVEOLIN; COMPLEMENTARY DNA; CONNECTIN; CYCLINE; MESSENGER RNA; NEUROPILIN; PROSTATE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RNA HELICASE; STATHMIN; CYCLIN G1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREEDING; CONTROLLED STUDY; DIET RESTRICTION; DNA LIBRARY; DOT HYBRIDIZATION; FEMALE; FETUS HEART; GENE EXPRESSION; GENETIC TRANSCRIPTION; GESTATIONAL AGE; HEART DEVELOPMENT; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; MATERNAL NUTRITION; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RANDOMIZATION; SHEEP; SMOOTH MUSCLE; TISSUE DISTRIBUTION; ALPHA ACTIN GENE; CARP GENE; CAVEOLIN GENE; CHAMP GENE; ESDN GENE; EWE; FETUS; G 1 CYCLIN GENE; GENE; NADH DEHYDROGENASE SUBUNIT 2 GENE; NUTRIENT; PROSTATIC BINDING PROTEIN GENE; STATHMIN GENE; TITIN GENE; UPREGULATION;

ANIMALS; BODY WEIGHT; CALORIC RESTRICTION; FEMALE; FETAL NUTRITION DISORDERS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE LIBRARY; HEART; HEART VENTRICLES; MYOCARDIUM; ORGAN SIZE; PREGNANCY; SHEEP; TRANSCRIPTION, GENETIC;

EID: 4043062109     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.061697     Document Type: Article

References (72)

1. Adachi S, Ito H, Ohta Y, Tanaka M, Ishiyama S, Nagata M et al. (1995). Distribution of mRNAs for natriuretic peptides in RV hypertrophy after pulmonary arterial banding. Am J Physiol 268, H162-H169.
2. Adachi S, Ito H, Tamamori M, Tanaka M, Marumo F & Hiroe M (1998). Skeletal and smooth muscle alpha-actin mRNA in endomyocardial biopsy samples of dilated cardiomyopathy patients. Life Sci 63, 1779-1791.
3. Aguilera A, Bajo MA, Rebollo F, Diez JJ, Diaz C, Paiva A et al. (2002). Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial 18, 212-217.
4. Aihara Y, Kurabayashi M, Saito Y, Ohyama Y, Tanaka T, Takeda S et al. (2000). Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension 36, 48-53.
5. Arnett DK (2000). Genetic contributions to left ventricular hypertrophy. Curr Hypertens Rep 2, 50-55.
6. Barker DJ (1994). Mothers Babies and Disease in Later Life. BMJ Publishing group, London.
7. Barker DJ (1995). Fetal origins of coronary heart disease. BMJ 311, 171-174.
8. Barker DJ (1998). Mothers, Babies and Health in Later Life. Harcourt Brace Ltd, Edinburgh.
9. Barker DJ, Martyn CN, Osmond C, Hales CN & Fall CH (1993). Growth in utero and serum cholesterol concentrations in adult life. BMJ 307, 1524-1527.
10. Barker DJ, Winter PD, Osmond C, Margetts B & Simmonds SJ (1989). Weight in infancy and death from ischaemic heart disease. Lancet 2, 577-580.
11. Baumeister A, Arber S & Caroni P (1997). Accumulation of muscle ankyrin repeat protein transcript reveals local activation of primary myotube endcompartments during muscle morphogenesis. J Cell Biol 139, 1231-1242.
12. Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ et al. (2002). A growth factor-dependent nuclear kinase phosphorylates p27 (Kip1) and regulates cell cycle progression. EMBO J 21, 3390-3401.
13. Boengler K, Pipp F, Fernandez B, Ziegelhoeffer T, Schaper W & Deindl E (2003). Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (carp). Cardiovasc Res 59, 573-581.
14. Brawley L, Torrens C, Anthony FW, Itoh S, Wheeler T, Jackson AA et al. (2004). Glycine rectifies vascular dysfunction induced by dietary protein imbalance during pregnancy. J Physiol 554, 497-504.
15. Brilla CG, Zhou G, Rupp H, Maisch B & Weber KT (1995). Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol 76, 8D-13D.
16. Burrell JH, Hegarty BD, McMullen JR & Lumbers ER (2001). Effects of gestation on ovine fetal and maternal angiotensin receptor subtypes in the heart and major blood vessels. Exp Physiol 86, 71-82.
17. Burrington JD (1978). Response to experimental coarctation of the aorta and pulmonic stenosis in the fetal lamb. J Thorac Cardiovasc Surg 75, 819-826.
18. Busk PK & Hinrichsen R (2003). Cyclin D in left ventricle hypertrophy. Cell Cycle 2, 91-95.
19. De Simone G, Pasanisi F & Contaldo F (2001). Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 38, 13-18.
20. Edwards LJ & McMillen IC (2001). Maternal undernutrition increases arterial blood pressure in the sheep fetus during late gestation. J Physiol 533, 561-570.
21. Egnaczyk GF, Pomonis JD, Schmidt JA, Rogers SD, Peters C, Ghilardi JR et al. (2003). Proteomic analysis of the reactive phenotype of astrocytes following endothelin-1 exposure. Proteomics 3, 689-698.
22. Fishman NH, Hof RB, Rudolph AM & Heymann MA (1978). Models of congenital heart disease in fetal lambs. Circulation 58, 354-364.
23. Galan HL, Hussey MJ, Chung M, Chyu JK, Hobbins JC & Battaglia FC (1998). Doppler velocimetry of growth-restricted fetuses in an ovine model of placental insufficiency. Am J Obstet Gynecol 178, 451-456.
24. 1 arrest via a p53/p21 (WAF1/Cip1)-dependent mechanism. Mol Biol Cell 12, 2229-2244.
25. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S et al. (1997). Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272, 25437-25440.
26. Ghosh S, Gachhui R, Crooks C, Wu C, Lisanti MP & Stuehr DJ (1998). Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J Biol Chem 273, 22267-22271.
27. Godfrey KM & Barker DJ (2000). Fetal nutrition and adult disease. Am J Clin Nutr 71, 1344S-1352S.
28. Godfrey K & Robinson S (1998). Maternal nutrition, placental growth and fetal programming. Proc Nutr Soc 57, 105-111.
29. Granzier H, Labeit D, Wu Y & Labeit S (2002). Titin as a modular spring: emerging mechanisms for elasticity control by titin in cardiac physiology and pathophysiology. J Muscle Res Cell Motil 23, 457-471.
30. Gutierrez-Cruz G, Van Heerden AH & Wang K (2001). Modular motif, structural folds and affinity profiles of the PEVK segment of human fetal skeletal muscle titin. J Biol Chem 276, 7442-7449.
31. Hawkins P, Steyn C, Ozaki T, Saito T, Noakes DE & Hanson MA (2000). Effect of maternal undernutrition in early gestation on ovine fetal blood pressure and cardiovascular reflexes. Am J Physiol Regul Integr Comp Physiol 279, R340-R348.
32. Hulit J, Bash T, Fu M, Galbiati F, Albanese C, Sage DR et al. (2000). The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem 275, 21203-21209.
33. Huq F, Heist EK & Hajjar RJ (2002). Titin - springing back to youth? Sci Aging Knowledge Environ 2002, pe20.
34. Ishizaka N, Griendling KK, Lassegue B & Alexander RW (1998). Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32, 459-466.
35. Kingdom JC, McQueen J, Connell JM & Whittle MJ (1993). Fetal angiotensin II levels and vascular (type I) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 100, 476-482.
36. Kobuke K, Furukawa Y, Sugai M, Tanigaki K, Ohashi N, Matsumori A et al. (2001). ESDN, a novel neuropilin-like membrane protein cloned from vascular cells with the longest secretory signal sequence among eukaryotes, is up-regulated after vascular injury. J Biol Chem 276, 34105-34114.
37. Kodama H, Fukuda K, Pan J, Makino S, Sano M, Takahashi T et al. (1998). Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes. Circ Res 82, 244-250.
38. Lahmers S, Wu Y, Call DR, Labeit S & Granzier H (2004). Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res 94, 505-513.
39. Langley SC & Jackson AA (1994). Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci (Lond) 86, 217-222; discussion 121.
40. Langley-Evans SC, Sherman RC, Welham SJ, Nwagwu MO, Gardner DS & Jackson AA (1999). Intrauterine programming of hypertension: the role of the renin-angiotensin system. Biochem Soc Trans 27, 88-93.
41. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH et al. (1995). Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270, 15693-15701.
42. Li JM, Poolman RA & Brooks G (1998). Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am J Physiol 275, H814-H822.
43. Liu ZP, Nakagawa O, Nakagawa M, Yanagisawa H, Passier R, Richardson JA et al. (2001). CHAMP, a novel cardiac-specific helicase regulated by MEF2C. Der Biol 234, 497-509.
44. Liu ZP & Olson EN (2002). Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase. Proc Natl Acad Sci U S A 99, 2043-2048.
45. Lucas A (1991). Programming by Early Nutrition in Man. John Wiley and Sons, Chichester, UK.
46. Martyn CN, Barker DJ & Osmond C (1996). Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 348, 1264-1268.
47. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K et al. (2003). The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J Mol Biol 333, 951-964.
48. Molnar J, Howe DC, Nijland MJ & Nathanielsz PW (2003). Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep. J Physiol 547, 61-66.
49. Molnar J, Nijland MJ, Howe DC & Nathanielsz PW (2002). Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am J Physiol Regul Integr Comp Physiol 283, R561-R567.
50. Nishina H, Green LR, McGarrigle HH, Noakes DE, Poston L & Hanson MA (2003). Effect of nutritional restriction in early pregnancy on isolated femoral artery function in mid-gestation fetal sheep. J Physiol 553, 637-647.
51. Nozato T, Ito H, Tamamori M, Adachi S, Abe S, Marumo F et al. (2000). G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II. Jpn Circ J 64, 595-601.
52. Ozaki T, Hawkins P, Nishina H, Steyn C, Poston L & Hanson MA (2000). Effects of undernutrition in early pregnancy on systemic small artery function in late-gestation fetal sheep. Am J Obstet Gynecol 183, 1301-1307.
53. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M et al. (2002). Caveolin-1/3 double-knockout mice are viable, bur lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 160, 2207-2217.
54. Pelletier G (2002). Effects of estradiol on prostate epithelial cells in the castrated rat. J Histochem Cytochem 50, 1517-1524.
55. Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M et al. (2003). Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 23, 1521-1527.
56. Rabkin SW, Goutsouliak V & Kong JY (1997). Angiotensin II induces activation of phosphatidylinositol 3-kinase in cardiomyocytes. J Hypertens 15, 891-899.
57. Reynolds LP & Redmer DA (1995). Utero-placental vascular development and placental function. J Anim Sci 73, 1839-1851.
58. Samson F, Bonnet N, Heimburger M, Rucker-Martin C, Levitsky DO, Mazmanian GM et al. (2000). Left ventricular alterations in a model of fetal left ventricular overload. Pediatr Res 48, 43-49.
59. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F & Kimura A (1999). Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 262, 411-417.
60. Segar JL, Dalshaug GB, Bedell KA, Smith OM & Scholz TD (2001). Angiotensin II in cardiac pressure-overload hypertrophy in fetal sheep. Am J Physiol Regul Integr Comp Physiol 281, R2037-R2047.
61. Sherman RC & Langley-Evans SC (1998). Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat. Clin Sci (Lond) 94, 373-381.
62. Stein CE, Fall CH, Kumaran K, Osmond C, Cox V & Barker DJ (1996). Fetal growth and coronary heart disease in south India. Lancet 348, 1269-1273.
63. Symonds ME, Gopalakrishnan G, Bispham J, Pearce S, Dandrea J, Mostyn A et al. (2003). Maternal nutrient restriction during placental growth, programming of fetal adiposity and juvenile blood pressure control. Arch Physiol Biochem 111, 45-52.
64. Taimor G, Schluter K & Piper HM (2001). Hypertrophy-associated gene induction after beta-adrenergic stimulation in adult cardiomyocytes. J Mol Cell Cardiol 33, 503-511.
65. Takahashi T, Kawahara Y, Okuda M, Ueno H, Takeshita A & Yokoyama M (1997). Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells, J Biol Chem 272, 16018-16022.
66. Tamamori M, Ito H, Hiroe M, Terada Y, Marumo F & Ikeda MA (1998). Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am J Physiol 275, H2036-H2040.
67. Thureen PJ, Trembler KA, Meschia G, Makowski EL & Wilkening RB (1992). Placental glucose transport in heat-induced fetal growth retardation. Am J Physiol 263, R578-R585.
68. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK et al. (2001). Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 276, 48269-48275.
69. Vonnahme KA, Hess BW, Hansen TR, McCormick RJ, Rule DC, Moss GE et al. (2003). Maternal undernutrition from early- to mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased liver weight in the fetal sheep. Biol Reprod 69, 133-140.
70. Weber KT, Sun Y & Campbell SE (1995). Structural remodelling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides. Eur Heart J 16 (Suppl. N), 12-18.
71. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J et al. (2002). Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277, 38988-38997.
72. Yoshimura, T Magness RR & Rosenfeld CR (1990). Angiotensin II and alpha-agonist. I. Responses of ovine fetoplacental vasculature. Am J Physiol 259, H464-H472.